CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Logo

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Biotech firm developing cell therapies for regenerative medicine and immunotherapy applications.

CELZ | NDAQ

Overview

Corporate Details

ISIN(s):
US22529Y3099
LEI:
Country:
United States of America
Address:
211 E. OSBORN RD., 85012 PHOENIX
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Creative Medical Technology Holdings, Inc. is a commercial-stage biotechnology company specializing in regenerative medicine and immunotherapy. The company focuses on developing novel biological therapeutics to address conditions in immunology, endocrinology, urogynecology, and orthopedics. It advances a portfolio of proprietary technology platforms, including supercharged autologous therapies, enhanced allogenic cell platforms, and reprogrammed cells. The company maintains a robust development pipeline, with recent milestones including receiving a Notice of Allowance for a patent covering the prevention and treatment of Type 1 Diabetes using modulated immune cells. Creative Medical Technology Holdings collaborates with various organizations to further the development of its technologies for sizable medical markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and genetically driven cancers.
United States of America BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Developing next-gen serotonergic drugs for neurological and psychiatric disorders like epilepsy.
United States of America DRUG
BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea 003000
Burning Rock Biotech Ltd Logo
Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.
United States of America BNR
C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America CCCC
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America CABA
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America CLDI

Talk to a Data Expert

Have a question? We'll get back to you promptly.